# The Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, Regulation 10: Amendments to Schedule 16


In Schedule 16 (patient group directions), in the table in Part 2 (persons on whose behalf a patient group direction must be signed)—
(a) in column 1 (class of person by whom product is supplied), at both places where it occurs, for “Public Health England” substitute “the United Kingdom Health Security Agency”; and
(b) in column 2 (person on whose behalf direction must be signed), at both places where it occurs, for “Public Health England” substitute “the United Kingdom Health Security Agency”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348262797/regulation/10 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendments-relating-to-naloxone-and-transfers-of-functions-regulations-2024/regulation-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

